Telehealth company Hims & Hers (HIMS: NYE) saw its stock price surge nearly 20% in early trading today after the company reported strong Q4 earnings. The company exceeded analyst expectations on both revenue and earnings per share (EPS).
Key Insights from Hims & Hers’ Q4 Report:
Below are the key insights from Hims & Hers’s Q4 report:
- Hims & Hers reported fourth-quarter revenue of $246.6 million, marking a substantial 47.5% increase compared to the previous year.
- The company surpassed analyst estimates of $245.82 million for their fourth-quarter revenue.
- Hims & Hers reported an EPS of $0.01, which exceeded expectations by $0.03.
Stock Target Advisor’s Take on HIMS & Hers:
Despite the positive earnings report and vision of CEO Dudum, Stock Target Advisor‘s analysis suggests a Strong Sell recommendation for Hims & Hers Health Inc. Average analyst target pricing for HIMS positions at $11.00 over the following year, and a Buy rating is advocated by most.
Contrarily, the bearish analysis by Stock Target Advisor derives from specific red flags like an overpriced stock value about book value bandwidth and high price volatility. However, certain positive signals identified by the Stock Target Advisor, specifically a high Gross Profit to Asset Ratio hint at underlying potential that could cause a reversal in consensus.
With respect to market analyst coverage for Hims & Hers, four analysts with a mean Buy rating have been keeping close tabs although the average analyst target pricing stands at $11. The Household & Personal Products sector, in which Hims & Hers operates, shows a slightly bearish outlook as per Stock Target Advisor.
Bottom Line:
The positive earnings report is a welcome sign for investors who have been watching the company closely. Hims & Hers has faced challenges in the past, but today’s report demonstrates the company’s potential for continued growth.
